The interplay between cardiovascular complications and diabetes presents a significant challenge in patient management. Chronic hyperglycemia, insulin resistance, and dyslipidemia contribute to atherosclerosis, increasing the risk of heart attacks and strokes. Emerging evidence supports the cardioprotective effects of GLP-1 receptor agonists and SGLT2 inhibitors, offering benefits beyond glucose control. Continuous monitoring of blood pressure, lipid profiles, and inflammatory markers is essential for early intervention. Lifestyle modifications, such as dietary adjustments and structured exercise programs, complement pharmacological strategies in reducing cardiovascular risk. Advances in precision cardiology and personalized treatments are paving the way for improved long-term outcomes in diabetic patients.
Submit your abstract Today
